CLINICAL PRACTICE GUIDANCE FOR RADIOTHERAPY PLANNING AFTER INDUCTION CHEMOTHERAPY IN LOCOREGIONALLY ADVANCED HEAD-AND-NECK CANCER

被引:82
|
作者
Salama, Joseph K. [1 ]
Haddad, Robert I. [2 ]
Kies, Merril S. [3 ]
Busse, Paul M. [4 ]
Dong, Lei [3 ]
Brizel, David M. [5 ]
Eisbruch, Avraham [6 ]
Tishler, Roy B. [2 ]
Trotti, Andy M. [7 ]
Garden, Adam S. [3 ]
机构
[1] Univ Chicago, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA
[2] Brigham & Womens Hosp, Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[4] Massachusetts Gen Hosp, Boston, MA 02114 USA
[5] Duke Univ, Med Ctr, Duke Comprehens Canc Ctr, Durham, NC 27710 USA
[6] Univ Michigan, Ann Arbor, MI 48109 USA
[7] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2009年 / 75卷 / 03期
关键词
Induction chemotherapy; Intensity-modulated radiotherapy; Radiotherapy planning; Head-and-neck cancer; INTENSITY-MODULATED RADIOTHERAPY; LOCALLY ADVANCED HEAD; SQUAMOUS-CELL CARCINOMA; STAGE NASOPHARYNGEAL CARCINOMA; RADIATION-THERAPY; CONCURRENT CHEMORADIOTHERAPY; FLUOROURACIL; IRRADIATION; CISPLATIN; DOCETAXEL;
D O I
10.1016/j.ijrobp.2008.11.059
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The use of induction chemotherapy (IC) for locoregionally advanced head-and-neck cancer is increasing. The response to IC often causes significant alterations in tumor volume and location and shifts in normal anatomy. Proper determination of the radiotherapy (RT) targets after IC becomes challenging, especially with the use of conformal and precision RT techniques. Therefore, a consensus conference was convened to discuss issues related to RT planning and coordination of care for patients receiving IC. Methods and Materials: Ten participants with special expertise in the various aspects of integration of IC and RT for the treatment of locoregionally advanced head-and-neck cancer, including radiation oncologists, medical oncologists, and a medical physicist, participated. The individual members were assigned topics for focused, didactic presentations. Discussion was encouraged after each presentation, and recommendations were formulated. Results: Recommendations and guidelines emerged that emphasize up-front evaluation by all members of the head-and-neck management team, high-quality baseline and postinduction planning scans with the patient in the treatment position, the use of preinduction target volumes, and the use of full-dose RT, even in the face of a complete response. Conclusion: A multidisciplinary approach is strongly encouraged. Although these recommendations were provided primarily for patients treated with IC, many of these same principles apply to concurrent chemoradiotherapy without IC. A rapid response during RT is quite common, requiring the development of two or more plans in a sizeable fraction of patients, and suggesting the need for similar guidance in the rapidly evolving area of adaptive RT. (C) 2009 Elsevier Inc.
引用
收藏
页码:725 / 733
页数:9
相关论文
共 50 条
  • [21] IMPROVED DOSIMETRIC AND CLINICAL OUTCOMES WITH INTENSITY-MODULATED RADIOTHERAPY FOR HEAD-AND-NECK CANCER OF UNKNOWN PRIMARY ORIGIN
    Chen, Allen M.
    Li, Bao-Qing
    Farwell, D. Gregory
    Marsano, Joseph
    Vijayakumar, Srinivasan
    Purdy, James A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (03): : 756 - 762
  • [22] Predictive factors of toxicity of TPF induction chemotherapy for locally advanced head and neck cancers
    Bernadach, Maureen
    Lapeyre, Michel
    Dillies, Anne-Francoise
    Miroir, Jessica
    Casile, Melanie
    Moreau, Juliette
    Molnar, Ioana
    Ginzac, Angeline
    Pham-Dang, Nathalie
    Saroul, Nicolas
    Durando, Xavier
    Biau, Julian
    BMC CANCER, 2021, 21 (01)
  • [23] Radiotherapy, chemotherapy and target therapy for treatment of head and neck cancer
    Knecht, R.
    HNO, 2009, 57 (05) : 436 - +
  • [24] Radiotherapy, chemotherapy and target therapy for treatment of head and neck cancer
    Knecht, R.
    HNO, 2009, 57 (05) : 436 - +
  • [25] Induction Chemotherapy Before Chemoradiotherapy in Locally Advanced Head and Neck Cancer: The Future?
    Paccagnella, Adriano
    Mastromauro, Cataldo
    D'Amanzo, Paola
    Ghi, Maria Grazia
    ONCOLOGIST, 2010, 15 : 8 - 12
  • [26] Induction chemotherapy in locally advanced head and neck cancers, is there a best choice?
    Mahdavi, Hoda
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2023, 186
  • [27] Induction Chemotherapy in the Management of Head and Neck Cancer
    Fury, Matthew G.
    Shah, Jatin P.
    JOURNAL OF SURGICAL ONCOLOGY, 2010, 101 (04) : 292 - 298
  • [28] Toxicity profile and clinical outcomes in locally advanced head and neck cancer patients treated with induction chemotherapy prior to concurrent chemoradiation
    Ko, Eric C.
    Genden, Eric M.
    Misiukiewicz, Krzysztof
    Som, Peter M.
    Kostakoglu, Lale
    Chen, Chien-Ting
    Packer, Stuart
    Kao, Johnny
    ONCOLOGY REPORTS, 2012, 27 (02) : 467 - 474
  • [29] Phase I/II study of induction chemotherapy plus concurrent chemotherapy and SMART-IMRT-based radiotherapy in locoregionally-advanced nasopharyngeal cancer
    Fan, Ting-Yong
    Xing, Jun
    Lu, Jie
    Liu, Tong-Hai
    Xu, Min
    Zhang, Ying-Jie
    Shao, Qian
    Li, Jian-Bin
    Yu, Jin-Ming
    ONCOLOGY LETTERS, 2013, 5 (03) : 889 - 895
  • [30] Induction chemotherapy before surgery for unresectable head and neck cancer
    Schmaltz, H.
    Borel, C.
    Ciftci, S.
    Takeda-Raguin, C.
    Debry, C.
    Schultz, P.
    Dupret-Bories, A.
    B-ENT, 2016, 12 (01): : 29 - 32